How Would Authorizing Medicare to Cover Anti-Obesity Medications Affect the Federal Budget?

Congressional Budget Office report estimating that authorizing Medicare coverage of anti-obesity medications would raise net federal spending by about $35 billion from 2026 to 2034, with highly uncertain estimates.